Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
588.29
-7.60 (-1.28%)
At close: Aug 14, 2026, 4:00 PM EDT
587.70
-0.59 (-0.10%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Thermo Fisher Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
46,33744,55742,87942,85744,91539,211
Other Revenue
-1-1----
46,33644,55642,87942,85744,91539,211
Revenue Growth
7.23%3.91%0.05%-4.58%14.55%21.70%
Cost of Revenue
27,34426,25425,13025,75725,94419,573
Gross Profit
18,99218,30217,74917,10018,97119,638
Selling, General & Admin
8,7738,5278,6028,4408,9407,857
Research & Development
1,4021,3971,3901,3371,4711,406
Other Operating Expenses
2020301-3
Operating Expenses
10,1959,94410,0229,77810,4119,266
Operating Income
8,7978,3587,7277,3228,56010,372
Interest Expense
-1,467-1,419-1,390-1,375-726-536
Interest & Investment Income
9329931,07887927243
Earnings From Equity Investments
-52-41-42-59-172-4
Currency Exchange Gain (Loss)
5266-16-29102162
Other Non Operating Income (Expenses)
-74-8955-35-161
EBT Excluding Unusual Items
8,1887,8687,3626,7438,0019,876
Merger & Restructuring Charges
-294-201-110-220-68-72
Gain (Loss) on Sale of Investments
-13-3821-46-16166
Asset Writedown
-154-94-252-219-46-122
Legal Settlements
----19--
Other Unusual Items
-141-267-26--63-911
Pretax Income
7,5867,2686,9956,2397,6638,837
Income Tax Expense
5985476572847031,109
Earnings From Continuing Operations
6,9886,7216,3385,9556,9607,728
Net Income to Company
6,9886,7216,3385,9556,9607,728
Minority Interest in Earnings
-21-17-340-10-3
Net Income
6,9676,7046,3355,9956,9507,725
Net Income to Common
6,9676,7046,3355,9956,9507,725
Net Income Growth
5.82%5.83%5.67%-13.74%-10.03%21.18%
Shares Outstanding (Basic)
374377382386392394
Shares Outstanding (Diluted)
375378383388394397
Shares Change
-1.44%-1.31%-1.29%-1.52%-0.76%-0.50%
EPS (Basic)
18.6317.7816.5815.5317.7319.61
EPS (Diluted)
18.5817.7416.5315.4517.6319.46
EPS Growth
7.45%7.32%6.99%-12.37%-9.40%21.93%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
7,3186,2937,2676,9276,9116,789
Free Cash Flow Per Share
19.5216.6518.9717.8517.5417.10
Dividend Per Share
1.8001.7201.5601.4001.2001.040
Dividend Growth
9.76%10.26%11.43%16.67%15.38%18.18%
Gross Margin
40.99%41.08%41.39%39.90%42.24%50.08%
Operating Margin
18.98%18.76%18.02%17.09%19.06%26.45%
Profit Margin
15.04%15.05%14.77%13.99%15.47%19.70%
Free Cash Flow Margin
15.79%14.12%16.95%16.16%15.39%17.31%
EBITDA
11,73911,13810,83510,72811,94112,964
EBITDA Margin
25.34%25.00%25.27%25.03%26.59%33.06%
D&A For EBITDA
2,9422,7803,1083,4063,3812,592
EBIT
8,7978,3587,7277,3228,56010,372
EBIT Margin
18.98%18.76%18.02%17.09%19.06%26.45%
Effective Tax Rate
7.88%7.53%9.39%4.55%9.17%12.55%
Revenue as Reported
46,33644,55642,87942,85744,91539,211
SEC Filings: 10-K · 10-Q